Guidance for Alexion Pharmaceuticals, Inc. (ALXN)
| Period | Range | Estimate | Revenue Range | Revenue Estimate | Target | Details |
|---|---|---|---|---|---|---|
| 2020 | $11.70 – $12.00 | $11.30 | $5.90B – 5.95B | $5.75B | = Maintained | Details |
| 2020 | $10.65 – $10.85 | $11.37 | $5.50B – 5.56B | $5.64B |  Lowered |
Details |
| 2020 | $10.45 – $10.75 | $11.01 | $5.23B – 5.33B | $5.60B | Lowered |
Details |
| 2020 | $10.65 – $10.95 | $10.88 | $5.55B – 5.60B | $5.41B |  Raised |
Details |
| 2019 | $9.10 – $9.30 | $8.73 | $4.63B – 4.70B | $4.75B | Raised |
Details |
| 2019 | $9.25 – $9.45 | $9.31 | $4.68B – 4.75B | $4.75B | Raised |
Details |
| 2019 | $10.25 – $10.40 | $9.94 | $4.86B – 4.89B | $4.85B | Raised |
Details |
| 2019 | $9.65 – $9.85 | $9.44 | $4.75B – 4.80B | $4.78B | = Maintained | Details |
| 2018 | $6.60 – $6.80 | $7.01 | $3.85B – 3.95B | $4.07B | Lowered |
Details |
| 2018 | $6.75 – $6.90 | $6.86 | $3.93M – 3.99M | $3.98M | = Maintained | Details |
| 2018 | $7.00 – $7.15 | $7.03 | $3.98M – 4.01M | $4.00M | = Maintained | Details |
| 2018 | $7.45 – $7.60 | $7.24 | $4.02B – 4.05B | $4.04B | = Maintained | Details |
| 2017 | $5.10 – $5.30 | $5.23 | N/A | N/A | Raised |
Details |
| 2017 | $5.00 – $5.25 | $5.54 | $3.40B – 3.50B | $3.54B | Lowered |
Details |
| 2017 | $5.40 – $5.55 | $5.33 | N/A | N/A | Raised |
Details |
| 2017 | $5.50 – $5.65 | $5.60 | $3.48M – 3.53M | $3.52M | Raised |
Details |
| 2016 | $5.00 – $5.20 | $5.50 | $3.05B – 3.10B | $3.20B | = Maintained | Details |
| 2016 | $4.50 – $4.65 | N/A | N/A | N/A | Lowered |
Details |
| 2016 | $4.50 – $4.65 | $4.67 | $3.05B – 3.10B | $3.08B | = Maintained | Details |
| 2015 | $4.70 – $4.80 | $4.98 | $2.60B – 2.62B | $2.63B | = Maintained | Details |
| 2015 | $4.92 – $4.97 | $4.82 | N/A | N/A | Raised |
Details |
| 2014 | $3.70 – $3.80 | $3.46 | $2.00B – 2.02B | $1.96B | = Maintained | Details |
| 2014 | $4.75 – $4.85 | $4.49 | N/A | N/A | Raised |
Details |
| 2013 | $2.87 – $2.97 | $2.90 | $1.51B – 1.52B | $1.51B | Raised |
Details |
| 2013 | $2.97 – $3.02 | $2.96 | $1.52B – 1.53B | $1.52B | Raised |
Details |
| 2013 | $3.02 – $3.04 | $3.03 | $1.54B – 1.54B | $1.53B | Raised |
Details |
| 2012 | $1.60 – $1.70 | $1.67 | $1.04B – 1.07B | $1.04B | = Maintained | Details |
| 2012 | $1.65 – $1.75 | $1.74 | $1.07B – 1.09B | $1.07B | = Maintained | Details |
| 2012 | $1.99 – $2.04 | $1.90 | $1.12B – 1.13B | $1.13B | Raised |
Details |
| 2012 | $1.78 – $1.88 | $1.80 | $1.11B – 1.13B | $1.09B | Raised |
Details |
| 2011 | $1.10 – $1.15 | $1.14 | $745.00M – 755.00M | $741.13M | Raised |
Details |
| 2011 | $1.25 – $1.28 | $1.19 | $770.00M – 775.00M | $767.40M | Raised |
Details |
